Gill Ruby K, Smith Zachary J, Panchal Ripul R, Bishop John W, Gandour-Edwards Regina, Wachsmann-Hogiu Sebastian
Center for Biophotonics, University of California, Davis, 95616, USA ; Department of Biomedical Engineering, University of California, Davis, 95616, USA ; These authors contributed equally to this work.
Center for Biophotonics, University of California, Davis, 95616, USA ; Department of Precision Machinery and Precision Instrumentation, University of Science and Technology of China, Hefei, Anhui, China ; These authors contributed equally to this work.
Biomed Opt Express. 2015 Nov 16;6(12):4850-8. doi: 10.1364/BOE.6.004850. eCollection 2015 Dec 1.
The aim of this study is to evaluate the capability of femtosecond Laser Induced Breakdown Spectroscopy (fsLIBS) to discriminate between normal and cancerous bone, with implications to femtosecond laser surgery procedures. The main advantage of using femtosecond lasers for surgery is that the same laser that is being used to ablate can also be used for a feedback system to prevent ablation of certain tissues. For bone tumor removal, this technique has the potential to reduce the number of repeat surgeries that currently must be performed due to incomplete removal of the tumor mass. In this paper, we performed fsLIBS on primary bone tumor, secondary tumor in bone, and normal bone. These tissues were excised from consenting patients and processed through the UC Davis Cancer Center Biorepository. For comparison, each tumor sample had a matched normal bone sample. fsLIBS was performed to characterize the spectral signatures of each tissue type. A minimum of 20 spectra were acquired for each sample. We did not detect significant differences between the fsLIBS spectra of secondary bone tumors and their matched normal bone samples, likely due to the heterogeneous nature of secondary bone tumors, with normal and cancerous tissue intermingling. However, we did observe an increase in the fsLIBS magnesium peak intensity relative to the calcium peak intensity for the primary bone tumor samples compared to the normal bone samples. These results show the potential of using femtosecond lasers for both ablation and a real-time feedback control system for treatment of primary bone tumors.
本研究的目的是评估飞秒激光诱导击穿光谱技术(fsLIBS)区分正常骨组织和癌性骨组织的能力,这对飞秒激光手术程序具有重要意义。使用飞秒激光进行手术的主要优势在于,用于消融的同一激光也可用于反馈系统,以防止对某些组织进行消融。对于骨肿瘤切除,该技术有可能减少因肿瘤块切除不完全而目前必须进行的重复手术次数。在本文中,我们对原发性骨肿瘤、骨继发性肿瘤和正常骨组织进行了飞秒激光诱导击穿光谱分析。这些组织取自同意参与的患者,并通过加州大学戴维斯分校癌症中心生物样本库进行处理。为作比较,每个肿瘤样本都有一个匹配的正常骨样本。通过飞秒激光诱导击穿光谱分析来表征每种组织类型的光谱特征。每个样本至少采集了20个光谱。我们未检测到骨继发性肿瘤及其匹配的正常骨样本的飞秒激光诱导击穿光谱之间存在显著差异,这可能是由于骨继发性肿瘤具有异质性,正常组织和癌性组织相互交织。然而,与正常骨样本相比,我们确实观察到原发性骨肿瘤样本的飞秒激光诱导击穿光谱中镁峰强度相对于钙峰强度有所增加。这些结果表明了使用飞秒激光进行消融以及用于原发性骨肿瘤治疗的实时反馈控制系统的潜力。